We intend to address various aspects within the broad field of biologics, including a focus on making biologics manufacturing processes more affordable, efficient and compliant with regulatory requirements.
We intend to cover following during the conference:
Cell line Engineering
Process Development
Potential and challenges of Cell and Gene Therapy
Allogenic model for cell therapy- possible ways forward
GMP production of Gene Therapy biologics
Cost reduction – proven approaches that work
Group discussion – how to get high protein titer while managing the quality of protein
Facility design
CAR T cells
New phase of iPSCs
Challenges in meeting regulatory requirements for large molecule/biosimilars
Start ups- New future and hope
and many more…
Why you should attend the conference
Become aware of the challenges in regulatory approval for biologics and how to overcome them
Case studies on protein quality and yield optimization for MAbs
Process development and scale up challenges and solutions
Cell therapy – distinct development and big steps by Indian companies
Latest on tech transfer and QC on biologics, including cell therapy products
Get to meet and have 1 to 1 discussion with industry leaders and scientists actively working in the field today
Who should attend the conference
Scientists (R&D, Process development and manufacturing) from Biotech companies (Vaccine, MAb and Cell Therapy fields)
Researchers from life sciences research institutes
Companies exploring markets for their products in India
Companies trying to increase market share in India
Venture Capitalist/Private Equity investigating investment opportunities in India
Regulatory and Quality Control professionals
Distributors of various solutions companies.
Any other person/company willing to gain more information on Indian Biotech landscape